| MDL | MFCD00865905 |
|---|---|
| Molecular Weight | 411.46 |
| Molecular Formula | C23H21N7O |
| SMILES | O=C1CCC2=C(C)N=C(C)N=C2N1CC3=CC=C(C4=CC=CC=C4C5=NNN=N5)C=C3 |
Tasosartan is a long-acting angiotensin II ( AngII ) receptor antagonist.
Angiotensin II (AngII) receptor [1]
Tasosartan is an orally active nonpeptide AngII antagonist that has demonstrates specific and selective AT1 receptor antagonistic activity in vitro. IC 50 for inhibition of specific binding of 125 I-AngII to rat adrenal membrane in the absence of proteins in binding buffer is 1.2±0.6 nM [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Administration of Tasosartan at doses of 1.0 and 3.0 mg/kg (iv) significantly (p<0.05) attenuates the pressor response to angiotensin-II in rats [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 125 mg/mL ( 303.80 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.4304 mL | 12.1518 mL | 24.3037 mL |
| 5 mM | 0.4861 mL | 2.4304 mL | 4.8607 mL |
| 10 mM | 0.2430 mL | 1.2152 mL | 2.4304 mL |